WCN26-4327 ROLE OF TFAM IN MANAGING DIABETIC KIDNEY DISEASE

Read full text Summarise with VIRAT
Authors: Antonio Miguel Fontanella, Rachel Njeim, Saeida Saadat, Judith Molina, George William Burke, Sandra Merscher, Alessia Fornoni, Alla V. Mitrofanova
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Diabetic kidney disease (DKD) is the leading cause of end-stage kidney disease in the U.S. Despite the rapid development of several therapies, the ability to target intrinsic kidney metabolic pathways remains somehow limited. Recently impaired mitophagy and innate immunity have been recognized as drivers of tubulointerstitial injury DKD. Our prior work discovered that glomeruli in experimental DKD exhibit sterile inflammation driven by stimulator of interferon genes (STING) activation, which results in podocyte apoptosis and autophagic death.

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Renal Diseases and Glomerulopathies Autophagy in Disease and Therapy

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104620–104620
Publication date
25 March 2026
Language
EN